Status:
COMPLETED
Doxycycline in Therapy of Erythema Migrans
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Lyme Borreliosis
Eligibility:
All Genders
15+ years
Brief Summary
The investigators will compare the outcome of three groups of erythema migrans patients treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and with severe symptoms...
Detailed Description
Patients with erythema migrans treated with doxycycline for two weeks will be followed-up for one year (at 2 weeks, 2, 6 and 12 months) clinically and also by filling in the questionnaire to assess th...
Eligibility Criteria
Inclusion
- presence of erythema migrans
- \>15 years old
- informed consent
Exclusion
- pregnancy
- lactation
- multiple erythema migrans
- already treated with antibiotic for this episode of Lyme borreliosis
- allergy to doxycycline
- treatment with drugs with known interactions with doxycycline
- cerebrospinal fluid pleocytosis
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01475708
Start Date
May 1 2011
End Date
November 1 2014
Last Update
March 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, Slovenia, 1000